Published in Cancer Weekly, July 26th, 2005
In a recently published study, investigators in the United States conducted a study "to determine the effect of taxane-based chemotherapy on intratumoral levels of COX-2 and prostaglandin E-2 (PGE2) in patients with NSCLC."
"Lung specimens obtained at the time of surgery were used to measure levels of COX-2 and PGE2 in tumors and adjacent nontumorous tissues in three subsets of NSCLC patients who underwent: (A) surgical resection only (n=16); (B) surgical resection after preoperative taxane-based chemotherapy (n=13); or (C)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.